Hiroyuki Watanabe1,*, Olga
Nosova1,*, Daniil Sarkisyan1,
Marlene Storm Andersen2, Mengliang
Zhang2,3, Linda Rorick-Kehn4,
Fredrik Clausen5, Liliana Carvalho6,
Nikolay Lukoyanov6, Kinga Gawel7,
Jan Kehr8, Jens Schouenborg3, Niklas
Marklund5 and Georgy Bakalkin1
1 Department of Pharmaceutical Biosciences,
Uppsala University, Uppsala, Sweden,
2 Department of Molecular Medicine,
University of Southern Denmark, Odense, Denmark,
3 Neuronano Research Center, Department of
Experimental Medical Science, Lund University, Lund, Sweden,
4 Lilly Research Laboratories, Eli Lilly and Company,
Indianapolis, IN 46285 USA,
5 Department of Neuroscience, Neurosurgery,
Uppsala University, Uppsala, Sweden,
6 Departamento de Biomedicina da Faculdade de Medicina
da Universidade do Porto, Instituto de Investigação e Inovação em Saúde,
Instituto de Biologia Molecular e Celular, Porto, Portugal,
7 Department of Experimental and Clinical
Pharmacology, Medical University of Lublin, Lublin, Poland, and
8 Department of Physiology and Pharmacology,
Karolinska Institutet, Sweden
* Contributed equally to this work
Correspondence to :
Georgy Bakalkin
Department of Pharmaceutical Biosciences
751 24 Uppsala, Sweden